Psilocybin-Research.comSearchable psilocybin and psilocin bibliometrics.
Researcher index

Authors in the psilocybin and psilocin literature

Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.

Sara De Martin

79 indexed publications match this author name.

ORCID
0000-0001-6398-8237
OpenAlex
https://openalex.org/A5137097004

Author watchlist

Create a confirmed email alert for new publications matching this author.

Publication history

Psilocybin-induced neurocardiogenic syncope: a case reportPsychopharmacology · 2026-05-27PsiConnect: Multimodal Neuroimaging of Context-Dependent Brain and Behaviour Dynamics under PsilocybinScientific Data · 2026-05-201080 Psilocybin Elicits Non-Linear Night to Night Changes in Sleep Spectral PowerSLEEP · 2026-04-30SAT-219 Hepatic 5-HT2B receptor antagonism mediates the anti-steatotic and antifibrotic effects of psilocybin in preclinical MASH modelsJournal of Hepatology · 2026-04-30356. Psilocybin Therapy is Associated With Decreases in Markers of Mitochondrial Stress and Inflammation in an Open-Label Clinical Trial of Parkinson’s DiseaseBiological Psychiatry · 2026-04-24Psilocybin and Ibogaine in Cocaine-Seeking: Extinction Enhancement Without Relapse PreventionAddiction Biology · 2026-02-28Design, Synthesis, and Pharmacokinetic Profiling of Fluorinated Reversible N -Alkyl Carbamate Derivatives of Psilocin for Sub-Hallucinogenic Brain ExposureJournal of Medicinal Chemistry · 2026-01-25Low, non-psychedelic doses of psilocybin as a novel treatment for MASLD, obesity and type 2 diabetes via 5-HT2B receptor-dependent mechanismsRepository for Publications and Research Data (ETH Zurich) · 2026-01-19The effects of psilocybin on time perception in humans: A comparative analysis of subjective and objective measuresJournal of Psychopharmacology · 2025-12-31Acute and post-dosing effects of single-dose psilocybin for obsessive-compulsive disorder in a randomized, double-blind, placebo-controlled trial: an interpretative phenomenological analysisFrontiers in Psychiatry · 2025-12-09Microdosing psilocybin and its effect on creativity: Lessons learned from three double-blind placebo controlled longitudinal trialsNeuropharmacology · 2025-11-01Psychedelics and ketamine/esketamine in depressive disorders: biological mechanisms and associated neuroimaging and clinical changes.Unknown journal · 2025-10-30Simulated 5-HT2A receptor activation accounts for the high complexity of brain activity during psychedelic statesbioRxiv · 2025-10-19Cognitive and subjective effects of psilocybin microdosing: Results from two double-blind placebo-controlled longitudinal trialsNeuropharmacology · 2025-10-16Emerging mechanisms of psilocybin-induced neuroplasticity.Unknown journal · 2025-09-14Global Increases in Brain Glucose Metabolism Following Acute N,N-Dimethyltryptamine and Harmine Administration in Healthy Volunteers: An [¹⁸F]FDG-PET StudyResearch Square · 2025-07-26Behavioural and pharmacological evaluation of the psilocybin analogue baeocystin in Wistar ratsProgress in Neuro-Psychopharmacology and Biological Psychiatry · 2025-06-30FRI-407 Adding the serotonergic agonist psilocybin to semaglutide as a novel combination therapy to cure MASLDJournal of Hepatology · 2025-04-30A Rapid Review of Psychedelic-Assisted Therapy in the Context of Palliative Care.Journal of hospice and palliative nursing: JHPN: the official journal of the Hospice and Palliative Nurses Association · 2025-03-31Beneficial effect of the combination psilocybin-semaglutide in a murine model of Steatotic Liver DiseaseDigestive and Liver Disease · 2025-01-31Direct effects of psilocybin on serotonin receptors regulate lipid accumulation in hepatic cells and adipocytesDigestive and Liver Disease · 2025-01-31Study Protocol for ‘PsilOCD: A Pharmacological Challenge Study Evaluating the Effects of the 5-HT2A Agonist Psilocybin on the Neurocognitive and Clinical Correlates of Compulsivity’Cureus · 2025-01-28A Rapid Review of Psychedelic-Assisted Therapy in the Context of Palliative Care.Unknown journal · 2024-12-18The Neurocircuitry of Substance Use Disorder, Treatment, and Change: A Resource for Clinical Psychiatrists.Unknown journal · 2024-10-08Change in occupational burnout measures in emergency medical service workers after a psychedelic experience induced by a single self-administered dose of psilocybin mushroomsJournal of Psychedelic Studies · 2024-09-08Psilocybin administered following extinction sessions does not affect subsequent cocaine cue reinstatement in male and female rats and miceNeuroscience · 2024-09-02THU-285 Lownonpsychedelic dosed of psilocybin for the therapy of MASLDJournal of Hepatology · 2024-05-31Psilocybin, peyote, mescaline, and lysergic acid diethylamide (LSD) use in a nationally representative population by cancer history.Journal of Clinical Oncology · 2024-05-31Content analysis of Reddit posts about coadministration of selective serotonin reuptake inhibitors and psilocybin mushroomsPsychopharmacology · 2024-04-29Corrigendum: Safety, feasibility, tolerability, and clinical effects of repeated psilocybin dosing combined with non-directive support in the treatment of obsessive-compulsive disorder: protocol for a randomized, waitlist-controlled trial with blinded ratings.Unknown journal · 2024-02-15Non-psychedelic doses of psilocybin as a novel therapeutic approach for MASLDDigestive and Liver Disease · 2024-01-31Safety, feasibility, tolerability, and clinical effects of repeated psilocybin dosing combined with non-directive support in the treatment of obsessive-compulsive disorder: protocol for a randomized, waitlist-controlled trial with blinded ratingsFrontiers in Psychiatry · 2024-01-08Psilocybin-induced default mode network hypoconnectivity is blunted in alcohol-dependent ratsTranslational Psychiatry · 2023-12-13Therapeutic Potential of Psilocybin for Treating Psychological Distress among Survivors of Adverse Childhood Experiences: Evidence on Acceptability and Potential Efficacy of Psilocybin UseJournal of Psychoactive Drugs · 2023-10-09DOES THE PHENOMENOLOGY OF THE PSILOCYBIN EXPERIENCE PREDICT LONG-TERM EFFECTS ON MOOD AND WELL-BEING IN HEALTHY VOLUNTEERS?IBRO Neuroscience Reports · 2023-09-30Knocking on the Doors of Perception: the role of psilocybin in substance use disorder treatmentUnknown journal · 2023-07-18Underlying pharmacological mechanisms of psilocin-induced broadband desynchronization and disconnection of EEG in ratsFrontiers in Neuroscience · 2023-06-21Psilocybin intoxication did not affect daytime or sleep-related declarative memory consolidation in a small sample exploratory analysisEuropean Neuropsychopharmacology · 2023-06-16Safety, tolerability, and clinical and neural effects of single-dose psilocybin in obsessive-compulsive disorder: protocol for a randomized, double-blind, placebo-controlled, non-crossover trialFrontiers in Psychiatry · 2023-04-24When art therapy went chemical: Alfred Bader, pharmacology, and art brut, c.1950-1970s.História Ciências Saúde-Manguinhos · 2023-01-05In Search of: A Federal Safe Harbor for State Legalization of PsilocybinUnknown journal · 2022-12-31Behavioral effects of a 14-day repeated treatment with psilocybin at a low non-psychedelic dose: a preliminary study in C57BL/6J miceNeuroscience Applied · 2022-12-31Extensive Collection of Psychotropic Mushrooms with Determination of Their Tryptamine Alkaloids.International Journal of Molecular Sciences · 2022-11-14Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression.New England Journal of Medicine · 2022-10-31Molecular Structure, Reactivity and Spectroscopic Properties of Hallucinogens Psilocybin, Mescaline and their Derivatives - A Computational StudyLetters in Applied NanoBioScience · 2022-09-16P03-21 Magic mushrooms and psilocybin: pharmacokinetics, pharmacodynamics, and clinical applicationsToxicology Letters · 2022-08-31Microdosing with psilocybin mushrooms: a double-blind placebo-controlled study.Translational Psychiatry · 2022-08-01Psilocybin-Mediated Attenuation of Gamma Band Auditory Steady-State Responses (ASSR) Is Driven by the Intensity of Cognitive and Emotional Domains of Psychedelic Experience.Journal of Personalized Medicine · 2022-06-18Natural language signatures of psilocybin microdosing.Psychopharmacology · 2022-06-08Psylocybin and Psilocin as new tools to fight depression: an overview of the Pharmacodynamic and pharmacokinetic mechanismsRevSALUS - Revista Científica da Rede Académica das Ciências da Saúde da Lusofonia · 2022-04-05Psilocybin-Induced Mystical-Type Experiences are Related to Persisting Positive Effects: A Quantitative and Qualitative Report.Frontiers in Pharmacology · 2022-03-08Psilocybin microdosing does not affect emotion-related symptoms and processing: A preregistered field and lab-based study.Journal of Psychopharmacology · 2021-12-16P.0729 Highlights of psychedelic history and current research on psilocybin application for treatment of depression - a comprehensive literature reviewEuropean Neuropsychopharmacology · 2021-11-30Lasting effects of a single psilocybin dose on resting-state functional connectivity in healthy individuals.Journal of Psychopharmacology · 2021-06-29Effects of psilocybin microdosing on awe and aesthetic experiences: a preregistered field and lab-based study.Psychopharmacology · 2021-04-29Molecular and Functional Imaging Studies of Psychedelic Drug Action in Animals and Humans.Unknown journal · 2021-04-21The Effects of Daytime Psilocybin Administration on Sleep: Implications for Antidepressant ActionFrontiers in Pharmacology · 2020-12-02The Effects of Daytime Psilocybin Administration on Sleep: Implications for Antidepressant ActionInstitutional Repositories DataBase (IRDB) · 2020-12-02Stability of psilocybin and its four analogs in the biomass of the psychotropic mushroom Psilocybe cubensisDrug Testing and Analysis · 2020-10-28A single psilocybin dose is associated with long-term increased mindfulness, preceded by a proportional change in neocortical 5-HT2A receptor bindingEuropean Neuropsychopharmacology · 2020-03-03Rapid-acting antidepressants.Unknown journal · 2019-04-23Psilocybin disrupts sensory and higher order cognitive processing but not pre-attentive cognitive processing-study on P300 and mismatch negativity in healthy volunteers.Psychopharmacology · 2018-01-04The Effects of Hallucinogens on Gene Expression.Unknown journal · 2017-12-31Psychoactive substances as a last resort-a qualitative study of self-treatment of migraine and cluster headaches.Harm Reduction Journal · 2017-09-04Proposal of 5-methoxy-N-methyl-N-isopropyltryptamine consumption biomarkers through identification of in vivo metabolites from mice.Unknown journal · 2017-06-04PM502. Effect of psilocybin on EEG brain connectivity in healthy volunteers - preliminary reportThe International Journal of Neuropsychopharmacology · 2016-05-26PM506. Psilocybin Clinical Trial: Acute Effects and its relationship to the brain activity as measured by quantitative EEGThe International Journal of Neuropsychopharmacology · 2016-05-26Neurovascular and neuroimaging effects of the hallucinogenic serotonin receptor agonist psilocin in the rat brain.Neuropharmacology · 2015-07-16Finding the self by losing the self: Neural correlates of ego-dissolution under psilocybin.Human Brain Mapping · 2015-05-21Analysis of psilocin, bufotenine and LSD in hair.Unknown journal · 2014-12-22Synthesis, hydrolysis and stability of psilocin glucuronide.Unknown journal · 2014-01-14Determination of psilocin, bufotenine, LSD and its metabolites in serum, plasma and urine by SPE-LC-MS/MS.Unknown journal · 2012-11-26A validated method for quantitation of psilocin in plasma by LC-MS/MS and study of stability.Unknown journal · 2011-12-02P.6.057 Effects of 2A receptor challenge by psilocybin on cognitive performance and neuroendocrine measures in healthy humans: A serotonin model of psychosisEuropean Neuropsychopharmacology · 2003-09-30Occurrence of psilocybin and psilocin in Psilocybe pseudobullacea (Petch) Pegler from the Venezuelan Andes.Unknown journal · 1994-06-30Relationship of CNS tryptaminergic processes and the action of LSD-like hallucinogens.Unknown journal · 1986-01-31The inhibition of food intake in the dog by LDS, mescaline, psilocin, d-amphetamine and phenylisopropylamine derivatives.Unknown journal · 1979-05-31The identification of LSD-like hallucinogens using the chronic spinal dog.Unknown journal · 1978-02-28The effects of psilocybin on primary process content in language.Unknown journal · 1976-12-31

Author directory

Carhart-Harris RL.58 publicationsVollenweider FX51 publicationsCarhart-Harris R50 publicationsGriffiths RR50 publicationsNutt DJ49 publicationsJohnson MW44 publicationsErritzoe D42 publicationsRoseman L41 publicationsRobin Carhart-Harris39 publicationsBarrett FS.34 publicationsPreller KH33 publicationsJohns Hopkins University31 publicationsKnudsen GM30 publicationsNutt D28 publicationsHendricks PS27 publicationsDavid Erritzøe25 publicationsRoland R. Griffiths25 publicationsGarcia-Romeu A23 publicationsDavid Nutt22 publicationsFranz X. Vollenweider22 publicationsGitte M. Knudsen22 publicationsPáleníček T.22 publicationsRosenblat JD22 publicationsFisher PM21 publicationsDavis AK20 publicationsDea Siggaard Stenbæk19 publicationsKargbo RB.19 publicationsKatrin H. Preller19 publicationsMcIntyre RS.19 publicationsStenbæk DS19 publicationsTimmermann C19 publicationsDos Santos RG18 publicationsLiechti ME18 publicationsPatrick M. Fisher18 publicationsRoss S18 publicationsYaden DB18 publicationsDeco G17 publicationsDirk Hoffmeister17 publicationsHusain MI17 publicationsKuypers KPC.17 publicationsM. Madsen17 publicationsMatthew W. Johnson17 publicationsSimonsson O17 publicationsTomáš Páleníček17 publicationsKringelbach ML.16 publicationsOzenne B16 publicationsSeifritz E16 publicationsBrice Ozenne15 publicationsFischer R.15 publicationsFrederick S. Barrett15 publicationsGonzález-Maeso J15 publicationsGuy M. Goodwin15 publicationsJoshua D. Rosenblat15 publicationsKettner H15 publicationsKwan AC.15 publicationsMadsen MK15 publicationsMason NL.15 publicationsNichols DE15 publicationsRamaekers JG15 publicationsUniversity Hospital15 publicationsYale University15 publicationsAlbert Garcia-Romeu14 publicationsBogenschutz MP14 publicationsGeyer MA.14 publicationsHalberstadt AL14 publicationsKometer M14 publicationsNayak SM14 publicationsBasel13 publicationsFeilding A13 publicationsGukasyan N.13 publicationsManish Agrawal13 publicationsNathan D. Sepeda13 publicationsSandeep M. Nayak13 publicationsSwitzerland13 publicationsTagliazucchi E13 publicationsGiribaldi B12 publicationsGoldberg SB12 publicationsHallak JEC.12 publicationsHasler F.12 publicationsHoffmeister D12 publicationsJames Rucker12 publicationsLerer B.12 publicationsLiknaitzky P12 publicationsMcCulloch DE12 publicationsRucker J.12 publicationsRucker JJ.12 publicationsYoung AH12 publicationsAgin-Liebes G11 publicationsBenyamina A11 publicationsBouso JC.11 publicationsGouzoulis-Mayfrank E11 publicationsHolze F11 publicationsJoshua Woolley11 publicationsKaelen M11 publicationsMartin Kuchař11 publicationsMuhammad Ishrat Husain11 publicationsNichols CD.11 publicationsOsika W11 publicationsScott T. Aaronson11 publicationsStephen Ross11 publicationsWang X.11 publicationsAnderson BT10 publicationsBarnett BS10 publicationsDavoudian PA10 publicationsErica Kaczmarek10 publicationsHoráček J10 publicationsHouman Farzin10 publicationsKovar KA.10 publicationsMatthias E. Liechti10 publicationsMichael P. Bogenschutz10 publicationsRoger S. McIntyre10 publicationsSchmid Y10 publicationsSchoevers RA10 publicationsUniversity of California10 publicationsVohryzek J10 publicationsZoe Doyle10 publicationsAaronson ST9 publicationsAndrea Mattarei9 publicationsArmand S9 publicationsBotvinnik A9 publications